Lisdexamfetamine dimesylate
Product Description
LABORATORIOS RUBIO SA
-
Country/Region:Spain
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
LABORATORIOS RUBIO SA
-
Country/Region:Spain
-
On CPHI since:2015
-
Certificates:4
-
Employees:250 - 499
Company types
Primary activities
More Products from LABORATORIOS RUBIO SA (13)
-
Product OWLiver® Non-invasive metabolomic test for liver disease
The OWLiver® test is a serum-based non-invasive test for detecting MASLD, MASH with moderate or no fibrosis F0-F1, and MASH with significant fibrosis F≥2.OWLiver® has been validated against the gold standard liver biopsy. The OWLiver® test is based on metabolomic technology that determines the activit... -
Product Methylphenidate Hydrochloride IR
IR - Treatment for children (over 6 years old) and adolescents with Attention Deficit and Hyperactivity Disorder (ADHD).
First Methylphenidate Hydrochloride launched in Spain (1983) with own trademark Rubifen®.
Rubifen® is a bioequivalent generic of Ritalin® in the treatment of ... -
Product Sodium Polystyrene Sulphonate
Treatment and prevention of Hyperkalaemia in adults and children.
The product has showed efficacy in the reduction of potassium.
Sugar-free product. Non-systemic absorption.
-
Product Liposcale(R) novel advanced test
The Liposcale(R) test is an advanced lipoprotein test based on nuclear magnetic resonance(NMR). From the analysis of serum or plasma samples by NMR, the concentration of cholesteroland triglycerides of the lipoprotein classes VLDL, IDL, LDL and HDL, the concentration ofparticles of the VLDL, LDL and HDL cl... -
Product Methylphenidate Hydrochloride MR
MR - Treatment for children (over 6 years old), adolescents and adults with Attention Deficit Hyperactivity Disorder (ADHD). Box containing 30 capsules of 10/20/30/40/60 mg. Other packs are also available.
Rubifen LA® is a bioequivalent generic of Ritalin LA® in the treatment of AD... -
Product Guanfacine Hydrochloride
Guanfacine is indicated for the treatment of Attention Deficit and Hyperactivity Disorder (ADHD) in children and adolescents (6-17 years old) for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.Guanfacine must be used as a part of a comprehensive ADHD treatment programm... -
Product Melatonin 1mg/ml Oral Solution
Sleep onset insomnia in children and adolescents (6-17 years of age) with attention deficit hyperactivity disorder (ADHD) where other healthy sleeping routines have not worked well enough.
Short-term treatment of jet lag in adults.
Strawberry flavour and contains Sorbitol.
Bibliogr... -
Product Melatonin 2mg prolonged -release
Monotherapy for the short-term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Dose: 2 mg once daily, 1-2 hours before bedtime and after food. This dosage may be continued for up to thirteen weeks.
Modified-release melatonin... -
Product Tadalafil ODT
.Treatment of erectile dysfunction in adult males.
In order for tadalafil to be effective for the treatment of erectile dysfunction, sexual stimulation is required.
5 mg only: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
... -
Product Cholestyramine Resin
Treatment of hypercholesterolaemia: lowering of total and LDL-cholesterol levels in patients with primaryhypercholesterolaemia, including familial hypercholesterolaemia, or secondary as a supplement diet and other treatments, when the response to these measures proves inadequate.
Pruritus associated t... -
Product Calcium Polystyrene Sulphonate
Treatment and prevention of hyperkalaemia in adults and children.
The product has showed efficacy in the reduction of potassium.
It is indicated for patients treated with dialysis with hyperkalaemia.
Sugar free product. Non-systemic absorption.
... -
Product Hydralazine Hydrochloride
Severe essential hypertension, when the oral route is not possible or a reduction in blood pressure is required urgently. Pre-eclampsia and eclampsia.
Registered and marketed in Spain since 1984.
CTD bibliographical dossier available.
